Wednesday, January 27, 2021

USFDA grants orphan drug designation to Zydus Cadila#39;s Saroglitazar Mg

USFDA grants orphan drug designation to Zydus Cadila#39;s Saroglitazar Mg Zydus Cadila, which is a part of Cadila Group, said orphan drug designation provides eligibility for certain development incentives, including tax credits for qualified clinical testing, prescription drug user fee exemptions and seven-year marketing exclusivity upon USFDA approval.

from Moneycontrol Business News https://ift.tt/3a9IPWL
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

What made Putin sell 22,000 kg gold from Russia this year?

Russia’s central bank has sold 21.8 tonnes or 22,000 kilograms of gold so far in 2026 to help fund the country’s widening budget deficit, wh...